Global Long-Read Metagenomics Market Report 2026 | Capitalize on 21.3% CAGR: Illumina, PacBio, Oxford Nanopore, QIAGEN, and BGI Genomics Accelerate AI Diagnostics
Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Long-Read Metagenomics Market Global Report 2026" has been added to ResearchAndMarkets.com's offering.
The global long-read metagenomics market is experiencing exponential growth, supported by advances in sequencing technology, microbiome research and genomic analytics. The market is projected to increase from $1.79 billion in 2025 to $2.16 billion in 2026, representing a compound annual growth rate (CAGR) of 21.1%.
Historical market growth has been driven by declining DNA sequencing costs, the expansion of next-generation sequencing platforms, increased investment in genomic research programs and the development of metagenomic assembly tools. Growing interest in microbiome analysis has also accelerated the adoption of long-read sequencing across research, healthcare and environmental applications.
Looking ahead, the long-read metagenomics market is forecast to reach $4.69 billion by 2030, expanding at a CAGR of 21.3%. Key growth factors include the adoption of precision medicine, the expansion of clinical metagenomics diagnostics, increasing use of real-time pathogen monitoring systems and rising demand for portable sequencing solutions. The integration of artificial intelligence into genomic analytics is also expected to improve data interpretation, workflow efficiency and sequencing accuracy.
Major long-read metagenomics market trends include high-resolution microbial strain identification, advanced error-correction and sequence-polishing algorithms, real-time pathogen surveillance using environmental DNA and ultra-deep metagenomic profiling for the detection of rare species. Improvements in sample preparation and high-molecular-weight DNA extraction are further enhancing the quality and reliability of long-read sequencing results.
The increasing burden of infectious diseases is a significant driver of market expansion. The emergence of antimicrobial-resistant pathogens and the growing frequency of disease outbreaks are creating demand for faster and more accurate pathogen detection. Long-read metagenomics supports the identification of pathogens, antimicrobial resistance genes and genomic variations in complex clinical and environmental samples. These capabilities strengthen disease surveillance, accelerate pathogen characterization and improve epidemiological monitoring across healthcare and public health systems.
In October 2024, the World Health Organization reported that approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, up from 7.5 million in 2022. The increase highlights the continued need for advanced genomic surveillance technologies that can support outbreak response, clinical research and infectious disease management.
Technology providers are responding by introducing high-throughput sequencing and genomic analysis solutions designed to automate workflows, improve variant detection and reduce bioinformatics costs. In February 2024, PacBio launched the HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for its Revio sequencing system. These library preparation solutions support microbial and metagenomic applications by enabling automated sample preparation, greater scalability, shorter workflow times and lower sequencing costs. HiFi long-read sequencing also supports complex metagenome assembly and detailed microbial community analysis.
Strategic partnerships are further advancing long-read sequencing applications. In July 2024, Oxford Nanopore Technologies partnered with Plasmidsaurus to expand the use of nanopore-based long-read sequencing in microbial genomics, plasmid analysis and metagenomic workflows. The collaboration aims to enhance sequencing accuracy, improve scalability, strengthen microbial genome assembly and accelerate the characterization of complex microbial communities for research and clinical applications.
North America led the long-read metagenomics market in 2025, reflecting the region's established genomic research infrastructure, technology adoption and investment in precision medicine. Asia-Pacific is expected to record rapid growth during the forecast period. The market analysis covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.
Countries included in the long-read metagenomics market analysis are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.
Markets Covered:
1) By Sequencing Technology Type: PacBio SMRT; Oxford Nanopore; Other Sequencing Technology Types
2) By Sample Type: Human; Animal; Environmental; Plant; Other Sample Types
3) By Technology Modality Type: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Synthetic Long-Read Or Linked-Read Assays
4) By End User Type: Academic And Research Institutes; Hospitals And Clinics; Biotechnology And Pharmaceutical Companies; Other End User Types
Subsegments:
1) By PacBio SMRT: High Fidelity Sequencing; Continuous Long Read Sequencing
2) By Oxford Nanopore: Ultra Long Read Nanopore Sequencing; Short To Medium Long Read Nanopore Sequencing
3) By Other Sequencing Technology Types: Synthetic Long Read Sequencing; Linked Read Sequencing
Time Series:
Five years historic and ten years forecast.
Data:
Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation:
Country and regional historic and forecast data, market share of competitors, market segments.
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/jfhjph
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.